Published in N Engl J Med on July 06, 1972
Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib. Exp Ther Med (2011) 1.26
Retracted Prognostic and predictive value of carcinoembryonic antigen and cytokeratin-19 fragments levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib. Yonsei Med J (2012) 1.20
Studies of carcinoembryonic antigen activity of whole and extracted serum in ulcerative colitis. Gut (1973) 0.89
Carcinoembryonic antigen and alpha 1-fetoprotein in ulcerative colitis and regional enteritis. Can Med Assoc J (1974) 0.89
Circulating carcinoembryonic antigen (CEA): relationship to clinical status of patients with inflammatory bowel disease. Gut (1973) 0.89
Carcinoembryonic antigen (CEA) "fingerprints". Br J Cancer (1973) 0.83
Carcinoembryonic antigen and prognosis in patients with colon cancer. Ann Surg (1975) 0.82
Carcinoembryonic antigen (CEA). Gut (1972) 0.80
Clinical significance of measurements of carcinoembryonic antigen in serum of patients with carcinoma of the uterine cervix. Arch Gynecol (1981) 0.75
Elevated serum CEA levels are associated with the explosive progression of lung adenocarcinoma harboring EGFR mutations. BMC Cancer (2017) 0.75
The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) (1976) 4.81
Demonstration of Reducing Enzyme Systems in Neoplasms and Living Mammalian Tissues by Triphenyltetrazolium Chloride. Science (1948) 3.77
Cholecystokinin and its COOH-terminal octapeptide in the pig brain. Proc Natl Acad Sci U S A (1977) 2.62
Reoperation and recurrence in Crohn's colitis and ileocolitis Crude and cumulative rates. N Engl J Med (1975) 2.59
Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut (1988) 2.51
Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology (1979) 2.48
A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer (1981) 1.83
How effective are current drugs for Crohn's disease? A meta-analysis. J Clin Gastroenterol (1992) 1.75
Gastropathy and ketoconazole malabsorption in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med (1988) 1.70
Response of the normal and pathological human gastric mucosa to an instilled acid load. Gastroenterology (1968) 1.59
Fecal alpha 1-antitrypsin measurement: an indicator of Crohn's disease activity. Gastroenterology (1985) 1.53
Cluster of inflammatory bowel disease in three close college friends? J Clin Gastroenterol (1993) 1.52
Imparied lymphocyte responsiveness in inflammatory bowel disease. Gastroenterology (1973) 1.51
Immunohistochemical localization in rabbit brain of a peptide resembling the COOH-terminal octapeptide of cholecystokinin. Proc Natl Acad Sci U S A (1977) 1.46
Patterns of neoplasia in Crohn's disease and ulcerative colitis. Cancer (1980) 1.45
Cancer in Crohn's disease after diversionary surgery. A report of seven carcinomas occurring in excluded bowel. Am J Surg (1978) 1.44
Perpetuation of published medical errors. Lancet (1993) 1.43
Short-term lymphocyte cultures in regional enteritis. Lancet (1970) 1.43
Risk factors for postoperative recurrence of Crohn's disease. Gastroenterology (1983) 1.43
Granulomatous ileocolitis. Gut (1966) 1.42
Anergy to dinitrochlorobenzene and depression of T-lymphocytes in Crohn's disease and ulcerative colitis. Gut (1976) 1.38
Glucose therapy in short-bowel syndrome. Lancet (1971) 1.36
Extraintestinal cancers in inflammatory bowel disease. Cancer (1985) 1.34
Recurrent regional ileitis after ileostomy and colectomy for granulomatous colitis. N Engl J Med (1972) 1.33
IV. Neuroanatomy of Williams syndrome: a high-resolution MRI study. J Cogn Neurosci (2000) 1.27
Cutaneous vasculitis complicating coeliac disease. Gut (1981) 1.27
Is there Kveim responsiveness in Crohn's disease? Lancet (1971) 1.26
Studies on the distribution and degradation of heptadecapeptide, big, and big big gastrin. Gastroenterology (1974) 1.26
Trauma and the pyoderma gangrenosum of inflammatory bowel disease. Gut (1981) 1.22
Chronic portal-systemic encephalopathy after ileostomy and colonic resection. Lancet (1966) 1.22
Species specificity of cholecystokinin in gut and brain of several mammalian species. Proc Natl Acad Sci U S A (1978) 1.21
Granulomatous diseases of the gastrointestinal tract. Annu Rev Med (1966) 1.20
Olsalazine sodium in the treatment of ulcerative colitis among patients intolerant of sulfasalazine. A prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial. Gastroenterology (1987) 1.19
Obstructive hydronephrosis. A frequent but seldom recognized complication of granulomatous disease of the bowel. N Engl J Med (1969) 1.18
Granulomatous colitis--pathogenetic concepts. Gastroenterology (1966) 1.17
Occurrence of Clostridium difficile toxin during the course of inflammatory bowel disease. Gastroenterology (1981) 1.16
Inhibition by diphenylhydantoin of folic acid absorption in man. Gastroenterology (1972) 1.16
Characterization of a nontrypsin cholecystokinin converting enzyme in mammalian brain. Proc Natl Acad Sci U S A (1978) 1.14
Hypersecretion of gastrin associated with the short bowel syndrome. Gastroenterology (1974) 1.14
Influence of glucagon on pancreatic exocrine secretion. Gastroenterology (1969) 1.12
Alcohol-stimulated secretion of immunoreactive secretin. N Engl J Med (1975) 1.12
Secretion of calcium by the canine pancreas. Gastroenterology (1967) 1.10
Granulomas do not affect postoperative recurrence rates in Crohn's disease. Gastroenterology (1982) 1.10
Radioimmunoassay of tuberculoprotein derived from Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (1980) 1.09
Outcome of toxic dilatation in ulcerative and Crohn's colitis. J Clin Gastroenterol (1985) 1.07
T and B lymphocytes and cutaneous anergy in inflammatory bowel disease. Ann N Y Acad Sci (1976) 1.07
The amylase-creatinine clearance ratio. Diagnostic parameter or physiologic phenomenon? Am J Gastroenterol (1974) 1.06
Mucosal blood flow in canine antral and fundic pouches. Gastroenterology (1971) 1.04
Lymphoma in inflammatory bowel disease. Cancer (1992) 1.03
Effect of secretin and acetazolamide on the volume and electrolyte composition of hepatic bile in man. Gastroenterology (1969) 1.02
Fractionation of immunoreactive cholecystokinin by adsorption to QUSO or talc. Life Sci (1979) 1.02
Studies in myasthenia gravis: biologic aspects. Mt Sinai J Med (1972) 1.02
Amyloidosis and inflammatory bowel disease. A 50-year experience with 25 patients. Medicine (Baltimore) (1992) 1.01
Clinical applications of the radioimmunoassay of secretory tuberculoprotein. Proc Natl Acad Sci U S A (1981) 1.01
Predicting the outcome of corticoid therapy for acute ulcerative colitis. Results of a prospective, randomized, double-blind clinical trial. J Clin Gastroenterol (1987) 1.00
Quality of life after surgery for Crohn's disease: a psychosocial survey. Gastroenterology (1980) 0.99
A family with collagenous colitis, ulcerative colitis, and Crohn's disease. Am J Gastroenterol (2000) 0.98
Myasthenia gravis. Cellular response to basic myelin protein compared with cellular and humoral immunity to muscle antigens. Neurology (1973) 0.97
Secretory capacity of stomach and pancreas in man. Gastroenterology (1967) 0.97
Immunotherapy of the Dunning leukaemia with thymic extracts. Br J Cancer (1973) 0.96
Treatment of ulcerative colitis with fish oil n--3-omega-fatty acid: an open trial. J Clin Gastroenterol (1990) 0.95
Adenocarcinoma in strictures of ulcerative colitis without antecedent dysplasia by colonoscopy. Am J Gastroenterol (1994) 0.95
Intraabdominal abscess in Crohn's (ileo) colitis. Am J Surg (1982) 0.95
"Natural history" of Crohn's disease. An analytic review of the placebo lesson. Gastroenterology (1984) 0.94
Effects of prostaglandin E1 on pancreatic exocrine function. Gastroenterology (1971) 0.94
Delayed hypersensitivity in alcoholic cirrhosis. Am J Dig Dis (1971) 0.93
Calcitonin and carcinoembryonic antigen as tumor markers in medullary thyroid carcinoma. Am J Clin Pathol (1978) 0.93
Autoimmune hemolytic anemia in ulcerative colitis: report of three cases, review of the literature, and evaluation of modes of therapy. Dig Dis Sci (1979) 0.92
Cancer in universal and left-sided ulcerative colitis: clinical and pathologic features. Mt Sinai J Med (1979) 0.92
Post-translational processing of cholecystokinin in pig brain and gut. Proc Natl Acad Sci U S A (1982) 0.92
Effect of glucagon on hepatic bile secretion in man. Gastroenterology (1971) 0.92
Folic acid and hexose absorption in sprue. Am J Dig Dis (1974) 0.91
Relationship of carcinoembryonic antigen to blood substances A and i: evidence that the antigenic sites are on different molecules. J Immunol (1974) 0.91
Immunoreactive secretin in gastrointestinal mucosa of several mammalian species. Gastroenterology (1978) 0.91
Complete duplication of the uterus and cervix with a unilaterally imperforate vagina. Obstet Gynecol (1982) 0.90
Radioimmunoassay of gastrointestinal hormones. Gastroenterology (1978) 0.90
The pancreas. Gastroenterology (1966) 0.90
Degradation of vasoactive intestinal polypeptide by tissue homogenates. Biochem Biophys Res Commun (1980) 0.90
Carcinoembryonic antigen (CEA): separation of CEA-reacting molecules from tumor, fetal gut, meconium and normal colon. Immunol Commun (1973) 0.90
Bile in the stomach. Gastroenterology (1969) 0.90
How effective is current medical therapy for severe ulcerative and Crohn's colitis? An analytic review of selected trials. J Clin Gastroenterol (1995) 0.90
Acute myelogenous leukemia in patients with ulcerative colitis. J Clin Gastroenterol (1980) 0.89
Localization of cholecystokinin-like immunoreactivity in isolated nerve terminals. Proc Natl Acad Sci U S A (1978) 0.89
Some metabolic aspects of exocrine pancreatic disease. Gastroenterology (1969) 0.89
Circulating carcinoembryonic antigen (CEA): relationship to clinical status of patients with inflammatory bowel disease. Gut (1973) 0.89
Rectourethroperineal fistula in Crohn's disease. Am J Gastroenterol (1985) 0.88
Fulminant herpes simplex hepatitis in a patient with ulcerative colitis. Gut (1988) 0.88
Colchicine therapy of the renal amyloidosis of ulcerative colitis. Gastroenterology (1988) 0.88
Cholecystokinin-converting enzymes in brain. Proc Natl Acad Sci U S A (1980) 0.88
Partial vaginal agenesis with a urinary-vaginal fistula. Obstet Gynecol (1981) 0.87
Controversy on recurrent ileitis after ileostomy: background and speculation. Gastroenterology (1973) 0.87
Carcinoma of the ileum 25 years after bypass for regional enteritis. A case report. Mt Sinai J Med (1971) 0.87
Carcinoembryonic antigen as a tissue marker in medullary thyroid carcinoma. N Engl J Med (1978) 0.87
Alterations in serum immunoglobulins after resection for ulcerative and granulomatous disease of the intestine. Gut (1972) 0.87
Toxic megacolon in ulcerative colitis complicated by pneumomediastinum: report of two cases. Gastroenterology (1980) 0.87
IgA: presence in meconium obtained from patients with cystic fibrosis. Pediatrics (1971) 0.87
Chemical analysis of ejaculates from patients with cystic fibrosis. Fertil Steril (1970) 0.87
Meta-analysis of the effectiveness of current drug therapy of ulcerative colitis. J Clin Gastroenterol (1993) 0.87